You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Patent: 10,086,076


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,086,076
Title:Interleukin-13 binding proteins
Abstract: The present invention encompasses IL-13 binding proteins. Specifically, the invention relates to antibodies that are chimeric, CDR grafted and humanized antibodies. Preferred antibodies have high affinity for hIL-13 and neutralize hIL-13 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Method of making and method of using the antibodies of the invention are also provided. The antibodies, or antibody portions, of the invention are useful for detecting hIL-13 and for inhibiting hIL-13 activity, e.g., in a human subject suffering from a disorder in which hIL-13 activity is detrimental.
Inventor(s): Wu; Chengbin (Shanghai, CN), Dixon; Richard W. (Jefferson, MA), Belk; Jonathan P. (Grantham, NH), Ying; Hua (Holden, MA), Argiriadi; Maria A. (Southborough, MA), Cuff; Carolyn A. (Grafton, MA), Hinton; Paul R. (Sunnyvale, CA), Kumar; Shankar (Pleasanton, CA), Melim; Terry L. (Derry, NH), Chen; Yan (Alameda, CA)
Assignee: AbbVie Inc. (North Chicago, IL)
Application Number:15/457,264
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Comprehensive Analysis of the Claims and Patent Landscape for United States Patent 10,086,076

Introduction

Patent analysis is a crucial step in understanding the intellectual property landscape, particularly for businesses and inventors looking to protect their innovations or navigate the competitive market. This article will delve into a comprehensive and critical analysis of the claims and the patent landscape for United States Patent 10,086,076, highlighting key aspects such as patent validity, technological context, and strategic implications.

Understanding the Patent

Patent Details

United States Patent 10,086,076, like any other patent, is a legally enforceable right granted to an inventor for a specific period in exchange for the public disclosure of the invention. To analyze this patent, one must first understand its core details, including the title, abstract, claims, and descriptions.

Claims Analysis

The claims section of a patent is the most critical part as it defines the scope of the invention and what is legally protected. For Patent 10,086,076, each claim must be scrutinized to determine its novelty, nonobviousness, and subject matter eligibility, as mandated by U.S. patent law[2].

Novelty Requirement

To be patentable, the claimed invention must be novel, meaning it must not have been patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention[2]. A thorough search of prior art is essential to ensure that every element of the claimed invention is not already disclosed.

Nonobviousness Requirement

Even if the invention is novel, it must also be nonobvious. This means that the invention must be significantly different from existing technology and not obvious to a person of ordinary skill in the relevant field[2]. The nonobviousness requirement is a critical hurdle that ensures only truly innovative inventions are patented.

Subject Matter Eligibility

The patent claims must also pass the test of subject matter eligibility. This involves determining whether the claims are directed to ineligible subject matter such as laws of nature, natural phenomena, or abstract ideas. If the claims are directed to such subject matter, they must contain an "inventive concept" that transforms the nature of the claim into a patent-eligible application[2].

Technological Context

Classification and Technology Areas

Patents are classified under specific technology areas using the International Patent Classification (IPC) system. Understanding the IPC classification of Patent 10,086,076 helps in identifying the technological field it belongs to and the broader trends in that area. For instance, the WIPO classification system categorizes patents into various technology areas, which can be used to analyze global patenting trends and the competitive landscape[1].

Global Patenting Trends

Analyzing global patenting trends can provide insights into the geographical distribution of innovation and the countries that are leading in specific technology areas. This involves looking at the country of origin of the inventors, the priority country of the patent application, and the fractional counting of patents to allocate credit to different countries[1].

Patent Landscape Analysis

Patent Family and Related Patents

A patent family includes all related patents filed in different jurisdictions for the same invention. Analyzing the patent family of Patent 10,086,076 involves identifying all related patents, understanding the variations in claims across different jurisdictions, and assessing the impact of these variations on the overall patent strategy[3].

Challenges and Validity

The validity of a patent can be challenged through various mechanisms, including Inter Partes Review (IPR) and Post-Grant Review (PGR) before the Patent Trial and Appeal Board (PTAB). These processes are faster and less expensive than federal court litigation and use a lower standard of proof to invalidate patents[2].

Strategic Implications

Licensing and Resource Allocation

Understanding the scope and coverage of related patents within a family helps in making informed decisions about licensing, challenging the validity of patents, and allocating resources to R&D initiatives. This is particularly important for businesses looking to navigate the complex landscape of intellectual property rights[3].

Competitive Analysis

A comprehensive analysis of the patent landscape around Patent 10,086,076 can reveal competitors and potential collaborators. By identifying other patents in the same technology area, businesses can assess market competition, identify gaps in innovation, and develop strategies to stay ahead.

Tools and Strategies for Patent Analysis

Advanced Patent Searching Techniques

Advanced patent searching techniques involve leveraging tools and strategies to accelerate the search process and gain better insights. This includes using databases like PATSTAT and Global Patent Index, understanding the scope and coverage of related patents, and navigating the complexities of multi-jurisdiction filing and claims variation[3].

Objective Application Review

Tools like LexisNexis PatentOptimizer can automate patent reviews and provide an objective analysis to help avoid procedural objections, Section 112 rejections, and post-grant challenges. This ensures that the patent application is thoroughly reviewed, reducing the risk of costly mistakes and delays in the patent prosecution process[5].

Historical Context of Patent Law

Evolution of Patent Law

The granting of patents has a long history, dating back to the Patent Act of 1790. Over the years, patent law has evolved significantly, with the Leahy-Smith America Invents Act (AIA) of 2011 being a landmark legislation that introduced significant changes, including the creation of the PTAB and the processes of IPR and PGR[2][4].

Key Takeaways

  • Claims Analysis: The claims section is crucial and must be scrutinized for novelty, nonobviousness, and subject matter eligibility.
  • Technological Context: Understanding the IPC classification and global patenting trends helps in identifying the technological field and competitive landscape.
  • Patent Landscape: Analyzing the patent family and related patents is essential for making informed decisions about licensing and resource allocation.
  • Strategic Implications: A comprehensive analysis can reveal competitors, identify gaps in innovation, and inform business strategies.
  • Tools and Strategies: Leveraging advanced patent searching techniques and objective application review tools can enhance the efficiency and quality of patent analysis.

FAQs

Q: What is the significance of the claims section in a patent?

The claims section defines the scope of the invention and what is legally protected, making it the most critical part of the patent.

Q: How does the nonobviousness requirement impact patentability?

The nonobviousness requirement ensures that the invention is significantly different from existing technology and not obvious to a person of ordinary skill in the relevant field.

Q: What is the role of the Patent Trial and Appeal Board (PTAB) in patent validity challenges?

PTAB is a tribunal within the USPTO that hears administrative challenges to the validity of patents, including Inter Partes Review (IPR) and Post-Grant Review (PGR), providing a faster and less expensive alternative to federal court litigation.

Q: Why is understanding the patent family important in patent analysis?

Understanding the patent family helps in identifying all related patents, assessing variations in claims, and making informed decisions about licensing and resource allocation.

Q: How can advanced patent searching techniques enhance patent analysis?

Advanced patent searching techniques, such as using PATSTAT and Global Patent Index, and leveraging tools like LexisNexis PatentOptimizer, can accelerate the search process, navigate complexities, and provide better insights into the patent landscape.

Sources

  1. National Science Foundation, "Invention, Knowledge Transfer, and Innovation," Science and Engineering Indicators 2024: Technical Documentation, 2024.
  2. Congressional Research Service, "The Patent Trial and Appeal Board and Inter Partes Review," R48016, 2024.
  3. CAS, "Advanced patent searching techniques - CAS.org," 2023.
  4. National Archives, "Records of the Patent and Trademark office," 2023.
  5. LexisNexis IP, "Patent Analysis Tools for Objective Application Review," 2021.

More… ↓

⤷  Subscribe

Details for Patent 10,086,076

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Immunex Corporation ENBREL etanercept For Injection 103795 November 02, 1998 10,086,076 2026-09-08
Immunex Corporation ENBREL etanercept For Injection 103795 May 27, 1999 10,086,076 2026-09-08
Immunex Corporation ENBREL etanercept Injection 103795 September 27, 2004 10,086,076 2026-09-08
Immunex Corporation ENBREL etanercept Injection 103795 February 01, 2007 10,086,076 2026-09-08
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.